MS patients won't take No for an answer

MS patients, and their families, are obviously starting to have an effect on federal intransigence toward the blocked vein treatment for multiple sclerosis.
The party line which trashed even doing any research into the possible treatment is starting to crack. The organization Direct MS has now done an analysis which concludes that Canadian medical scientists whose research is supported by drug companies should not be the ones deciding whether research into a non-drug treatment for MS is justified:

This would be like asking oil company executives if we need a definitive study on climate change.